Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SurgicEye is a private German medical technology company developing and commercializing intraoperative 3D imaging and navigation systems for nuclear medicine-guided procedures. Founded as a spinout from the Technical University of Munich in 2008, the company focuses on radio-guided surgery, hybrid SPECT/ultrasound imaging, and interventional guidance tools used in oncology and endocrine surgery. Its flagship declipseSPECT platform and related products support localization of radioactive structures, sentinel lymph node mapping, and image-guided soft-tissue procedures. In addition to product sales, SurgicEye has provided engineering and development support for medical imaging, navigation, and radionuclide therapy applications. The company appears to be an active private medtech company rather than a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SurgicEye.